<VariationArchive VariationID="3068719" VariationName="NM_004366.6(CLCN2):c.61dup (p.Leu21fs)" VariationType="Duplication" Accession="VCV003068719" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-20" DateCreated="2024-04-15" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3228046" VariationID="3068719">
      <GeneList>
        <Gene Symbol="CLCN2" FullName="chloride voltage-gated channel 2" GeneID="1181" HGNC_ID="HGNC:2020" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q27.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="184346185" stop="184361605" display_start="184346185" display_stop="184361605" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="184063972" stop="184079438" display_start="184063972" display_stop="184079438" Strand="-" />
          </Location>
          <OMIM>600570</OMIM>
        </Gene>
        <Gene Symbol="LOC129938055" FullName="ATAC-STARR-seq lymphoblastoid silent region 14964" GeneID="129938055" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q27.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="184361380" stop="184361969" display_start="184361380" display_stop="184361969" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_004366.6(CLCN2):c.61dup (p.Leu21fs)</Name>
      <CanonicalSPDI>NC_000003.12:184361418:GGG:GGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q27.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="184361418" stop="184361419" display_start="184361418" display_stop="184361419" variantLength="1" positionVCF="184361418" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="184079206" stop="184079207" display_start="184079206" display_stop="184079207" variantLength="1" positionVCF="184079206" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>L21fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.184079209dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.184079209dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.184361421dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.184361421dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016422.1" sequenceAccession="NG_016422" sequenceVersion="1" change="g.5185dup">
            <Expression>NG_016422.1:g.5185dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_171065.1" sequenceAccession="NG_171065" sequenceVersion="1" change="g.142dup">
            <Expression>NG_171065.1:g.142dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171087.3" sequenceAccession="NM_001171087" sequenceVersion="3" change="c.61dup">
            <Expression>NM_001171087.3:c.61dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001164558.1" sequenceAccession="NP_001164558" sequenceVersion="1" change="p.Leu21fs">
            <Expression>NP_001164558.1:p.Leu21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171088.3" sequenceAccession="NM_001171088" sequenceVersion="3" change="c.61dup">
            <Expression>NM_001171088.3:c.61dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001164559.1" sequenceAccession="NP_001164559" sequenceVersion="1" change="p.Leu21fs">
            <Expression>NP_001164559.1:p.Leu21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171089.3" sequenceAccession="NM_001171089" sequenceVersion="3" change="c.61dup">
            <Expression>NM_001171089.3:c.61dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001164560.1" sequenceAccession="NP_001164560" sequenceVersion="1" change="p.Leu21fs">
            <Expression>NP_001164560.1:p.Leu21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004366.6" sequenceAccession="NM_004366" sequenceVersion="6" change="c.61dup" MANESelect="true">
            <Expression>NM_004366.6:c.61dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004357.3" sequenceAccession="NP_004357" sequenceVersion="3" change="p.Leu21fs">
            <Expression>NP_004357.3:p.Leu21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004366.6(CLCN2):c.61dup (p.Leu21fs) AND Leukoencephalopathy with mild cerebellar ataxia and white matter edema" Accession="RCV003994782" Version="1">
        <ClassifiedConditionList TraitSetID="13146">
          <ClassifiedCondition DB="MedGen" ID="C4554120">Leukoencephalopathy with mild cerebellar ataxia and white matter edema</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-04-15" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32173090</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13146" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18592" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Leukoencephalopathy with ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukoencephalopathy with white matter edema</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brain white matter edema</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leukoencephalopathy with mild cerebellar ataxia and white matter edema</ElementValue>
                <XRef ID="MONDO:0014292" DB="MONDO" />
                <XRef ID="363540" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CC2D</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LKPAT</ElementValue>
                <XRef Type="MIM" ID="615651" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000559496" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529356" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17565" />
                <XRef ID="17565" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CLCN2-related leukoencephalopathy is characterized by nonspecific neurologic findings, mild visual impairment from chorioretinopathy or optic atrophy, male infertility, and characteristic findings on brain MRI. Neurologic findings include mild ataxia (action tremor and gait instability following initially normal motor development; occasionally, mild spasticity), cognitive impairment in some (typically mild, rarely severe), psychiatric symptoms in some (depression and schizophrenia-like symptoms), headaches in some (usually intermittent, severe, and diffuse) and auditory symptoms in some (hearing loss, tinnitus, vertigo). Affected individuals remain ambulatory, do not require support for walking, and rarely become blind. To date CLCN2-related leukoencephalopathy has been reported or identified in 31 individuals from 30 families. It is not yet known if the findings occurring in a few individuals (i.e., epilepsy and paroxysmal kinesigenic dyskinesia) are part of the phenotypic spectrum or unrelated findings.</Attribute>
                <XRef ID="NBK326661" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CLCN2-Related Leukoencephalopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26539602</ID>
                <ID Source="BookShelf">NBK326661</ID>
              </Citation>
              <XRef ID="363540" DB="Orphanet" />
              <XRef ID="C4554120" DB="MedGen" />
              <XRef ID="MONDO:0014292" DB="MONDO" />
              <XRef Type="MIM" ID="615651" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8997740" SubmissionDate="2024-04-11" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="SUB14373874" submittedAssembly="GRCh38" title="SUB14373874" />
        <ClinVarAccession Accession="SCV004812252" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Department Of Biochemistry, Hamamatsu University School Of Medicine" OrgID="509106" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">32173090</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>East Asia</Ethnicity>
              <GeographicOrigin>Japan</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>NextSeq500</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002352" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN2">
              <Name>chloride voltage-gated channel 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004366.6:exon 1</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004366.6:c.61dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615651" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14373874</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8997740" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002352" MappingRef="HP">
        <MedGen CUI="C0270612" Name="Leukoencephalopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8997740" TraitType="Disease" MappingType="XRef" MappingValue="615651" MappingRef="OMIM">
        <MedGen CUI="C4554120" Name="Leukoencephalopathy with mild cerebellar ataxia and white matter edema" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

